Aurora Cannabis (ACB) EBITDA Margin (2018 - 2025)
Historic EBITDA Margin for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to 19.62%.
- Aurora Cannabis' EBITDA Margin fell 23700.0% to 19.62% in Q4 2025 from the same period last year, while for Dec 2025 it was 28.97%, marking a year-over-year increase of 203300.0%. This contributed to the annual value of 4.86% for FY2025, which is 20100.0% down from last year.
- Aurora Cannabis' EBITDA Margin amounted to 19.62% in Q4 2025, which was down 23700.0% from 68.06% recorded in Q3 2025.
- Aurora Cannabis' EBITDA Margin's 5-year high stood at 133.36% during Q1 2021, with a 5-year trough of 1243.94% in Q2 2022.
- In the last 5 years, Aurora Cannabis' EBITDA Margin had a median value of 4.42% in 2024 and averaged 55.91%.
- In the last 5 years, Aurora Cannabis' EBITDA Margin plummeted by -12117000bps in 2022 and then skyrocketed by 12084800bps in 2023.
- Aurora Cannabis' EBITDA Margin (Quarter) stood at 10.29% in 2021, then soared by 123bps to 2.34% in 2022, then skyrocketed by 368bps to 10.93% in 2023, then soared by 101bps to 21.99% in 2024, then dropped by -11bps to 19.62% in 2025.
- Its EBITDA Margin stands at 19.62% for Q4 2025, versus 68.06% for Q3 2025 and 11.05% for Q2 2025.